Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 4/2019

16.01.2019 | Original Article

Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis

verfasst von: Entsar A. Saad, Heba M. Waly

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Searching for novel anticancer therapeutics which are effective and primarily less toxic is urgently needed. Drug encapsulation provides more protection of drug within the body with more stable drug circulation levels thus avoiding drug peak-related adverse effects. We aimed first to develop and characterize a nano-particulate drug delivery system using poly(lactic-co-glycolic acid) (PLGA) for the new compound N-butylpyridoquinoxaline 1,4-dioxide (NBPQD), and second to investigate its anticancer effect and the probable mechanism.

Methods

NBPQD–PLGA nano-particles were prepared and their shape, size, zeta potential, encapsulation efficiency (EE%), drug loading (DL%), drug release, anticancer activity against six human cancer cell lines, DNA binding ability, and flow cytometric analyses of apoptosis, cell cycle and caspase-3 activity were investigated.

Results and conclusions

NBPQD–PLGA nano-particles were spherical with diameter around 54 nm. Zeta potential, EE%, and DL% values were − 20.4 mV, 88% and 21.8%, respectively. Nano-particles exhibited higher marked anticancer activities (much lower IC50s) and changed the anticancer potency pattern towards all the studied cell lines compared to free NBPQD with superior potency against colorectal carcinoma (HCT-116, IC50 of 12.2 µg/mL). NBPQD–PLGA acts by induction of cancer cell apoptosis through oxidative stress, DNA damage, and activating a caspase-3 signaling pathway.
Literatur
1.
Zurück zum Zitat El-Emshaty HM, Saad EA, Gouida MS, Elshahawy ZR (2018) Associations between CD133, CK19 and G2/M in cirrhotic HCV (genotype-4) patients with or without accompanying tumor. Biocell 42(2):55–60CrossRef El-Emshaty HM, Saad EA, Gouida MS, Elshahawy ZR (2018) Associations between CD133, CK19 and G2/M in cirrhotic HCV (genotype-4) patients with or without accompanying tumor. Biocell 42(2):55–60CrossRef
2.
Zurück zum Zitat Attallah A, El-Far M, Abdel Malak C, Omran M, Farid K, Yahya R et al (2015) A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Ann Hepatol 14:869–880CrossRefPubMed Attallah A, El-Far M, Abdel Malak C, Omran M, Farid K, Yahya R et al (2015) A simple diagnostic index comprising epithelial membrane antigen and fibronectin for hepatocellular carcinoma. Ann Hepatol 14:869–880CrossRefPubMed
6.
Zurück zum Zitat Nagajyothi PC, Muthuraman P, Sreekanth TVM, Kim DH, Shim J (2017) Green synthesis: in-vitro anticancer activity of copper oxide nanoparticles against human cervical carcinoma cells. Arabian J Chem 10:215–225CrossRef Nagajyothi PC, Muthuraman P, Sreekanth TVM, Kim DH, Shim J (2017) Green synthesis: in-vitro anticancer activity of copper oxide nanoparticles against human cervical carcinoma cells. Arabian J Chem 10:215–225CrossRef
7.
Zurück zum Zitat Wang H, Zhao Y, Wu Y, Hu Y, Nan K, Nie G et al (2011) Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32:8281–8290CrossRefPubMed Wang H, Zhao Y, Wu Y, Hu Y, Nan K, Nie G et al (2011) Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32:8281–8290CrossRefPubMed
8.
Zurück zum Zitat Dias DJS, Joanitti GA, Azevedo RB, Silva LP, Lunardi CN, Gomes AJ (2015) Chlorambucil encapsulation into PLGA nanoparticles and cytotoxic effects in breast cancer cell. J Biophysical Chem 6:1–13CrossRef Dias DJS, Joanitti GA, Azevedo RB, Silva LP, Lunardi CN, Gomes AJ (2015) Chlorambucil encapsulation into PLGA nanoparticles and cytotoxic effects in breast cancer cell. J Biophysical Chem 6:1–13CrossRef
9.
Zurück zum Zitat Al-Mutairi FM, Abdel-Daim MM, Ibrahim IT, Habib SA, Waly HM (2016) The potent effect of a newly synthesized N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) derivative as antitumor agent in solid tumor model. Int J Pharm Res Allied Sci 5:203–218 Al-Mutairi FM, Abdel-Daim MM, Ibrahim IT, Habib SA, Waly HM (2016) The potent effect of a newly synthesized N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) derivative as antitumor agent in solid tumor model. Int J Pharm Res Allied Sci 5:203–218
10.
Zurück zum Zitat Habib SA, Ibrahim IT, Abd-Eldaye MA, El-Sheshtawey MM, Waly HM (2012) N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) as a new potent for tumor imaging and therapy. Nat Sci 4:1074–1084 Habib SA, Ibrahim IT, Abd-Eldaye MA, El-Sheshtawey MM, Waly HM (2012) N-Butylpyridoquinoxaline 1,4-dioxide (NBPQD) as a new potent for tumor imaging and therapy. Nat Sci 4:1074–1084
11.
Zurück zum Zitat Homan KA, Chen J, Schiano A, Mohamed M, Willets KA, Murugesan S et al (2011) Silver–polymer composite stars: synthesis and applications. Adv Funct Mater 21:1673–1680CrossRefPubMedPubMedCentral Homan KA, Chen J, Schiano A, Mohamed M, Willets KA, Murugesan S et al (2011) Silver–polymer composite stars: synthesis and applications. Adv Funct Mater 21:1673–1680CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Li XL, Li RT, Qian X, Ding Y, Tu Y, Guo R, Hu Y et al (2008) Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 70:726–734CrossRefPubMed Li XL, Li RT, Qian X, Ding Y, Tu Y, Guo R, Hu Y et al (2008) Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 70:726–734CrossRefPubMed
13.
Zurück zum Zitat Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA et al (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 349:287–291CrossRef Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA et al (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 349:287–291CrossRef
14.
Zurück zum Zitat Burres NS, Frigo A, Rasmussen RR, McAlpine JB (1992) A colorimetric microassay for the detection of agents that interact with DNA. J Nat Prod 55:1582–1587CrossRefPubMed Burres NS, Frigo A, Rasmussen RR, McAlpine JB (1992) A colorimetric microassay for the detection of agents that interact with DNA. J Nat Prod 55:1582–1587CrossRefPubMed
16.
Zurück zum Zitat Chuan L, Jia Z, Yu-Jiao Z, Shu-Fang N, Jun C, Qian W et al (2015) Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med 13:641–652PubMedCentral Chuan L, Jia Z, Yu-Jiao Z, Shu-Fang N, Jun C, Qian W et al (2015) Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med 13:641–652PubMedCentral
17.
Zurück zum Zitat Borah A, Palaninathan V, Girija AR, Balasubramanian S, Rochani AK, Maekawa T (2017) Poly-lactic-co-glycolic acid nanoformulation of small molecule antagonist GANT61 for cancer annihilation by modulating hedgehog pathway. NanoWorld J 3:1–10CrossRef Borah A, Palaninathan V, Girija AR, Balasubramanian S, Rochani AK, Maekawa T (2017) Poly-lactic-co-glycolic acid nanoformulation of small molecule antagonist GANT61 for cancer annihilation by modulating hedgehog pathway. NanoWorld J 3:1–10CrossRef
18.
Zurück zum Zitat Lee MS, Dees EC, Wang AZ (2017) Nanoparticle-delivered chemotherapy: old drugs in new packages. Oncology J 31:198–208 Lee MS, Dees EC, Wang AZ (2017) Nanoparticle-delivered chemotherapy: old drugs in new packages. Oncology J 31:198–208
19.
Zurück zum Zitat Heydari R, Rashidipour M (2015) Green synthesis of silver nanoparticles using extract of Oak fruit hull (jaft): synthesis and in vitro cytotoxic effect on MCF-7 cells. Int J Breast Cancer 846743:1–6CrossRef Heydari R, Rashidipour M (2015) Green synthesis of silver nanoparticles using extract of Oak fruit hull (jaft): synthesis and in vitro cytotoxic effect on MCF-7 cells. Int J Breast Cancer 846743:1–6CrossRef
24.
Zurück zum Zitat Habib SA, Saad EA, Elsharkawy AA, Attia ZR (2015) Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: Interrelations with obesity in Egyptian non-diabetic obese children and adolescents. Adv Med Sci 60:179–185CrossRefPubMed Habib SA, Saad EA, Elsharkawy AA, Attia ZR (2015) Pro-inflammatory adipocytokines, oxidative stress, insulin, Zn and Cu: Interrelations with obesity in Egyptian non-diabetic obese children and adolescents. Adv Med Sci 60:179–185CrossRefPubMed
25.
Zurück zum Zitat Saad EA, Habib SA, Refai WA, Elfayoumy AA (2017) Malondialdehyde, adiponectin, nitric oxide, C-reactive protein, tumor necrosis factor-alpha and insulin resistance relationships and inter-relationships in type 2 diabetes early stage. Is metformin alone adequate in this stage? Int J Pharm Pharm Sci 9(10):176–181. https://doi.org/10.22159/ijpps.2017v9i10.21149 CrossRef Saad EA, Habib SA, Refai WA, Elfayoumy AA (2017) Malondialdehyde, adiponectin, nitric oxide, C-reactive protein, tumor necrosis factor-alpha and insulin resistance relationships and inter-relationships in type 2 diabetes early stage. Is metformin alone adequate in this stage? Int J Pharm Pharm Sci 9(10):176–181. https://​doi.​org/​10.​22159/​ijpps.​2017v9i10.​21149 CrossRef
27.
Zurück zum Zitat Saad EA, Toson EA, Ahmed GM (2015) Clove or green tea administration antagonizes khat hepatotoxicity in rats. Int J Pharm Pharm Sci 7(6):72–76 Saad EA, Toson EA, Ahmed GM (2015) Clove or green tea administration antagonizes khat hepatotoxicity in rats. Int J Pharm Pharm Sci 7(6):72–76
30.
Zurück zum Zitat Priyadarsini KI, Dennis MF, Naylor MA, Stratford MRL, Wardman P (1996) Free radical intermediates in the reduction of quinoxaline N-oxide antitumor drugs: redox and prototropic reactions. J Am Chem Soc 118:5648–5654CrossRef Priyadarsini KI, Dennis MF, Naylor MA, Stratford MRL, Wardman P (1996) Free radical intermediates in the reduction of quinoxaline N-oxide antitumor drugs: redox and prototropic reactions. J Am Chem Soc 118:5648–5654CrossRef
32.
Zurück zum Zitat Azqueta A, Pachon G, Cascante M, Creppy EE, Lopez de Cerain A (2005) DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay. Mutagenesis 20:165–171CrossRefPubMed Azqueta A, Pachon G, Cascante M, Creppy EE, Lopez de Cerain A (2005) DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay. Mutagenesis 20:165–171CrossRefPubMed
33.
Zurück zum Zitat Frankfurt OS, Krishan A (2003) Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Antican Drugs 14:555–561CrossRef Frankfurt OS, Krishan A (2003) Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Antican Drugs 14:555–561CrossRef
36.
Zurück zum Zitat Vaja F, Guran C, Ficai D, Ficai A, Oprea O (2014) Cytotoxic effects of ZnO nanoparticles incorporated in mesoporous silica. UPB Sci Bull 76:55–66 Vaja F, Guran C, Ficai D, Ficai A, Oprea O (2014) Cytotoxic effects of ZnO nanoparticles incorporated in mesoporous silica. UPB Sci Bull 76:55–66
37.
Metadaten
Titel
Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis
verfasst von
Entsar A. Saad
Heba M. Waly
Publikationsdatum
16.01.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 4/2019
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-019-03770-0

Weitere Artikel der Ausgabe 4/2019

Cancer Chemotherapy and Pharmacology 4/2019 Zur Ausgabe

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.